Contact Lenses Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Contact Lenses stocks.

Contact Lenses Stocks Recent News

Date Stock Title
May 24 JNJ Johnson & Johnson (JNJ) Stock Falls Amid Market Uptick: What Investors Need to Know
May 24 NVS After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
May 24 NVS Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday
May 24 COO Insights Into The Cooper Companies (COO) Q2: Wall Street Projections for Key Metrics
May 23 NVS ADHD diagnoses increasing, becoming an 'expanding public health concern': CDC
May 23 JNJ ADHD diagnoses increasing, becoming an 'expanding public health concern': CDC
May 23 COO CooperCompanies’ 2023 Environmental, Social, and Governance Report Highlights Efforts that Benefit People and the Planet
May 23 JNJ Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma Companies
May 23 JNJ ASCO24: An early look at cancer drug study results
May 23 JNJ Johnson & Johnson: Vital Signs Decent, A Compelling Value Case
May 23 ALC Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?
May 23 ALC Do Options Traders Know Something About Alcon (ALC) Stock We Don't?
May 23 ALC Buy 5 Medical Instruments Stocks to Enhance Your Portfolio
May 23 JNJ J&J faces lawsuit over talc-related bankruptcy filings
May 22 JNJ Is Eli Lilly and Company the Largest Publicly Traded Healthcare Company?
May 22 BLCO Bausch + Lomb Corporation: Spin-Off Ready To Fly Troubled Nest And Find Upside
May 22 JNJ Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies
May 22 JNJ Top Midday Stories: US Targets August 1 Start Date for China Tariff Hikes; CFPB Says BNPL Requires Credit Card-Level Oversight; Target Shares Fall on Earnings Miss; Third BHP Bid Rejected by Anglo American
May 22 JNJ J&J’s Tremfya superior to Stelara in Phase II/III Chron’s disease trials
May 22 COO Cooper Companies' (NASDAQ:COO) investors will be pleased with their notable 35% return over the last five years
Contact Lenses

Contact lens, or simply contacts, are thin lenses placed directly on the surface of the eyes. Contact lenses are ocular prosthetic devices used by over 150 million people worldwide, and they can be worn to correct vision or for cosmetic or therapeutic reasons. In 2010, the worldwide market for contact lenses was estimated at $6.1 billion, while the US soft lens market was estimated at $2.1 billion. Multiple analysts estimated that the global market for contact lenses would reach $11.7 billion by 2015. As of 2010, the average age of contact lens wearers globally was 31 years old, and two-thirds of wearers were female.People choose to wear contact lenses for many reasons. Aesthetics and cosmetics are the main motivating factors for people who want to avoid wearing glasses or to change the appearance of their eyes. Others wear contact lenses for functional or optical reasons. When compared with spectacles, contact lenses typically provide better peripheral vision, and do not collect moisture (from rain, snow, condensation etc.) or perspiration. This can make them preferable for sports and other outdoor activities. Contact lens wearers can also wear sunglasses, goggles, or other eyewear of their choice without having to fit them with prescription lenses or worry about compatibility with glasses. Additionally, there are conditions such as keratoconus and aniseikonia that are typically corrected better with contact lenses than with glasses.

Browse All Tags